Meta-level question: how do you evaluate evidence for memantine when the human data is thin and most trials are small?
Most of the popular protocols are borrowed from clinical populations and applied to healthy people without comment.
There is a serious question about whether the studied form matches what is sold, and nobody in a thread can answer it.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
Posting to be argued with, mainly.
Baseline first.
Stupid question: how do you know whether what is in the vial matches the label at all?
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing. Not on memantine but the pattern is familiar.
Same here.
Read the methods section. It is the only part that says whether the conclusion is allowed to exist.